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Abstract
Background: Approximately 1 out of every 100 individuals has some form of venous insufficiency,
which can lead to chronic venous disease and Venous Leg Ulcer (VLU). There are known
underlying pathologies which contribute to the chronic nature of VLU including biofilm phenotype
infections.
Results:  Using pyrosequencing based approaches we evaluated VLU to characterize their
microbial ecology. Results show that VLU infections are polymicrobial with no single bacterium
colonizing the wounds. The most ubiquitous and predominant organisms include a previously
uncharacterized bacteroidales, various anaerobes, Staphylococcus, Corynebacterium, and Serratia.
Topological analysis of VLU show some notable differences in bacterial populations across the
surface of the wounds highlighting the importance of sampling techniques during diagnostics.
Metagenomics provide a preliminary indication that there may be protozoa, fungi and possibly an
undescribed virus associated with these wounds.
Conclusion: The polymicrobial nature of VLU and previous research on diabetic foot ulcers and
surgical site infections suggest that the future of therapy for such wounds lies in the core of the
logical and proven multiple concurrent strategy approach, which has been termed "biofilm-based
wound care" and the use of individualized therapeutics rather than in a single treatment modality.
Background
Approximately 600,000 Americans suffer from venous leg
ulcers (VLU), which are extremely costly to manage and
produce significant suffering [1]. Hippocrates believed
that VLU were the bodies way to vent "evil humors" and
advocated such ulcers should not be treated. His philoso-
phy was that such ulcers should be allowed to express
these evil humors naturally [2,3]. In spite of Hippocrates'
beliefs, the modern clinical goal is to treat and cure VLU.
Venous insufficiency is becoming epidemic with almost
half of all females and one quarter of all males estimated
to suffer from this disease [4]. It is generally agreed that
chronic venous disease (CVD) is caused by persistent
venous hypertension in the lower extremities stemming
from a decay in the efficiency and performance of one-
way valves in perforating, superficial or deep veins.
Published: 27 October 2009
BMC Microbiology 2009, 9:226 doi:10.1186/1471-2180-9-226
Received: 15 April 2009
Accepted: 27 October 2009
This article is available from: http://www.biomedcentral.com/1471-2180/9/226
© 2009 Wolcott et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Microbiology 2009, 9:226 http://www.biomedcentral.com/1471-2180/9/226
Page 2 of 11
(page number not for citation purposes)
Venous hypertension in the extremities, results in clinical
changes leading from edema and pain (exacerbated upon
standing for long periods of time) through lipodermato-
sclerosis, hyperpigmentation, hyperkeratosis and ulti-
mately to a proclivity for the development of chronic VLU
[1].
As the underlying pathology associated with CVD devel-
ops, ulcers typically start when the skin, in the area of fluid
accumulation, becomes physically injured (e.g. cuts and
abrasions). Because circulation is compromised due to
associated pathologies, the effectiveness of the area to heal
is reduced along with the overall functioning of the local
immune system. The underlying pathological process,
from the host perspective, still represents an area of devel-
oping hypotheses and has been reviewed recently in the
literature [5]. A fully comprehensive, all encompassing
understanding of the developmental mechanism related
to why VLU remain chronic remains elusive and from a
clinical perspective, Brem et al. stated "the exact mecha-
nism underlying the formation of venous ulceration is
unknown" [6].
VLU formation and their chronic nature is associated with
a complex and multifactorial process. A primary factor
contributing to the chronic nature of VLU is now known
to be polymicrobial biofilm infection. The fact that many
venous leg ulcers persist even after venous hypertension is
adequately corrected clinically, is key evidence that this
biofilm phenotype infection of the wound bed contrib-
utes significantly to the persistence associated with VLU. It
is logical that this impaired host environment is extremely
susceptible to opportunistic bacteria, which can then
establish chronic infections. It also is logical that the con-
tribution of biofilm to the production and persistence of
VLU was overlooked until recently because its molecular
footprint is so similar to the inflammation produced by or
attributed solely to venous hypertension [7].
The current study was undertaken to better characterize
the bacterial ecology of VLU using modern next-genera-
tion approaches [8-13]. Understanding the bacterial ecol-
ogy of VLU associated biofilm is a critical next step in
further evaluating the contribution of the wound microbi-
ome to establishing and promoting the chronicity of VLU
[14]. Using bTEFAP, metagenomic, quantitative PCR and
the new bTEFAP Titanium based methods the bacterial
diversity of 40 separate VLU, the overall metagenomic
diversity in a pool of 10 VLU, and the topological bacterial
diversity of 8 separate VLU are evaluated. This study rep-
resents one of the most comprehensive evaluations of
microbial diversity in chronic wounds to date. The overall
goal is to determine if VLU have the bacterial diversity
between individual samples that we have shown with dia-
betic foot ulcers [9] and surgical site infections [13] and to
do a preliminary screening of the total microbial diversity
in these chronic wounds based upon a next-generation
metagenomic approach. This metagenomic approach was
also expected to help us to determine if there are any nota-
ble differences seen between a de novo approach to bacte-
rial composition when compared to the 16s ribosomal
DNA bTEFAP approach [15].
Results and Discussion
Diversity among 40 VLU
Using the bTEFAP methodology the diversity of 40 differ-
ent VLU were individually evaluated. A total of 59,571
individual sequence reads longer than 200 bp were evalu-
ated among the 40 samples with 46,993 sequences gener-
ating BLASTn hits against the bacterial database. The
average sequence identity was 97.5%. A total of 16,029
sequences had identity below 97% suggesting they repre-
sented uncharacterized bacteria. The majority of these
unknown organisms were most closely related based
upon 16S sequence to Bacterioides, Paludibacter, Pseu-
domonas, Finegoldia, and Corynebacterium spp. These bacte-
ria, which can be considered unknown or previously
uncharacterized bacterial species, were identified based
upon their closest identification and ranked at the genus,
family or order level as appropriate. Only 101 of the total
number of analyzed sequences fell below 80% identity
and were not considered in subsequent analyses.
A total of 62 different genera (occurring in at least 2 of the
wounds) were identified among the 40 wounds indicating
a large relative diversity. The top 25 unique and most
ubiquitous species (or closest taxonomic designation) are
indicated in Table 1. The most ubiquitous genera were, in
order and unknown Bacteroides, Staphylococcus aureus, and
Corynebacterium spp The Bacteroides was only of marginal
identity to any known Bacteroides species, thus represents
a previously uncharacterized type of wound bacteria. Sev-
eral genera were found in high percentage in individual
wounds (Figure 1 dendogram). Staphylococcus spp. (which
included primarily S. aureus but also several other coagu-
lase negative species) predominated in 11 of the wounds,
the unknown Bacteroidetes (which may represent a new
genus based upon their identity) predominated in 8 of the
wounds, Serratia (tenatively marcescens) was a predomi-
nant population in 6 of the wounds, Streptococcus, Finegol-
dia,  Corynebacterium  and  Peptoniphilus  spp. were the
predominant genera in 2 wounds each, while Proteus and
Pseudomonas  spp. were the major population in one
wound each. The remaining wounds were highly diverse
with no overwhelmingly predominant populations. It is
interesting that so many of these wounds were predomi-
nated by what are likely strict anaerobic bacteria with only
very minor populations of facultative or strict aerobes.
This suggests that such anaerobes might be contributing
to the etiology of such biofilm infections. Figure 1 indi-BMC Microbiology 2009, 9:226 http://www.biomedcentral.com/1471-2180/9/226
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cates there are a number of important functional equiva-
lent pathogroups [9] associated with VLU. At a relative
distance of 5 based upon the weighted-pair linkage and
Manhattan distance we note there are 11 total clusters,
which included 4 predominant clusters representing pos-
sible pathogroups [9]. It is also evident that Staphylococcus,
Serratia, and Bacterioides are the defining variables for 3 of
these 4 clusters. From this data we note that 53% of the
populations were gram positive, 51.5% are facultative
anaerobes, 30% were strict anaerobes, and 58% were rod
Double dendogram of major genera in Venous Leg Ulcers Figure 1
Double dendogram of major genera in Venous Leg Ulcers. This figure is a double dendogram describing the major 
genera detected among the 40 VLU samples. The heat map indicates the relative percentage of the given genera within each 
sample ID with a color legend and scale provided. The distance of the samples based upon weighted pair linkage and Manhattan 
distance methods with no scaling is provided at the top of the figure along with a distance score. The bacterial genera and the 
associated clustering are provided along the Y-axis and their associated distance scores indicated. The most determinative gen-
era for clustering, based upon this analysis, are Staphylococcus, Bacteroides, Serratia, and Corynebacterium spp.BMC Microbiology 2009, 9:226 http://www.biomedcentral.com/1471-2180/9/226
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Table 1: Evaluation of primary genera and species among the 40 VLU samples.
ID Num of Samples Avg % St Dev Min % Max %
Bacteroidales A 22 28.2 34.8 0.1 98.1
Staphylococcus aureus 19 41.5 37.0 0.2 97.4
Finegoldia magna 14 12.3 26.8 <0.1 80.0
Serratia marcescens 12 43.0 42.6 0.1 99.0
Staphylococcus aureus 12 0.4 0.4 <0.1 1.1
Corynebacterium spp. 11 22.7 26.8 0.1 90.2
Peptoniphilus harei 11 16.9 26.1 <0.1 82.0
Escherichia coli 8 6.9 9.4 0.1 26.0
Anaerococcus prevotii 8 4.1 7.4 0.1 22.2
Pseudomonas aeruginosa 7 19.4 30.7 0.1 86.7
Staphylococcus spp. 7 2.0 4.5 0.1 12.1
Propionibacterium acnes 7 1.1 1.5 0.1 4.4
Staphylococcus auricularis 6 3.1 7.1 0.1 17.5
Prevotella bryantii 6 1.1 1.1 0.1 3.1
Anaerococcus vaginalis 5 2.7 3.2 0.2 6.7
Corynebacterium spp. 4 10.5 11.7 0.2 26.1
Staphylococcus haemolyticus 4 8.2 8.6 0.4 16.7
Bacteroidales B 4 2.8 3.8 0.2 8.5
Staphylococcus capitis 4 0.4 0.4 0.1 1.0
Streptococcus agalactiae 3 48.2 42.2 0.2 79.6
Porphyromonas somerae 3 7.8 11.8 0.3 21.5
Streptococcus agalactiae 3 6.6 5.2 0.6 9.8
Prevotella marshii 3 1.7 2.5 0.1 4.5
Streptococcus spp. 3 1.5 2.5 <0.1 4.3
Actinomyces europaeus 3 0.7 0.8 0.1 1.6
The primary identification based upon percent sequence identity as described in the materials and methods is indicated. For genera followed by spp. 
this indicates that resolution between multiple species of the same genera was not possible. The Bacteroidales designation represents the closest 
possible relationship for these previously uncharacterized bacteria. There is a second Bacteroidales (designated B), which also occurs in 4 of the 
wounds. Because these identifications are based upon average 250 bp such designations should be considered tentative at the species level. The 
results were however validated using quantitative PCR. The number of samples each bacteria was detected in is provided along with the average 
percent (avg %) among the positive samples, the standard deviation (st dev) and the range of percentages among the positive samples is provided.BMC Microbiology 2009, 9:226 http://www.biomedcentral.com/1471-2180/9/226
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shaped bacteria. Supplementary data (see additional file
1) provides a secondary comprehensive evaluation of the
bacterial diversity in each of the 40 wounds.
As a confirmatory step for the bTEFAP diversity study we
utilized a quantitative PCR wound diagnostic panel (Path-
ogenius diagnostics, Lubbock, TX), described previously
[12,16]. A total of 8 of the VLU samples were chosen
because they contained a predicted predominance of bac-
teria targeted by the qPCR wound panel. The results of the
qPCR were provided to us in the form of relative ratios of
each detected bacterium in the sample and these results
compared to the corresponding bTEFAP bacterial ratio
data. In short the percentages of the key bacteria detected
using bTEFAP analysis were correlated (0.78, P = 0.001)
with the relative percentages determined using qPCR. This
provides an indication of the validity of the bTEFAP data.
Metagenomics
We evaluated, using a bulk pyrosequencing metagenom-
ics approach, a uniformly compiled pool of 10 VLU DNA
extractions. A total of 178,610 individual reads were gen-
erated averaging 248 bp. There were 42,441 reads that
could be assigned taxonomic designations. Of those reads
assigned to a taxonomic designation the majority
(30,141) fell into the chordata, which represents human
genetic information confirmed based upon subsequence
BLASTn and BLASTx designations to homo sapiens
genomic data contained within NCBI. The remaining
reads were utilized to generate an evaluation of the micro-
bial population within these 10 VLU samples. There were
7,497 reads, which were assigned to bacteria, which was
evaluated at the class level for the subsequent compari-
sons. Table 1 provides a comparative breakdown at the
bacterial class level of bTEFAP analyses and the metagen-
omic analysis. There was good overall relationship (r-
squared = 0.74) with what was predicted in the 10-sample
VLU pool using metagenomic data and what was detected
using the same 10 sample pool analyzed in our previous
work using bTEFAP [15]. Interestingly, there was also a
positive relationship at the same class taxonomic level
between the 10-sample pool and the averages of the 40
VLU samples at the class level (Table 2).
Further analysis of the metagenomic data in relation to
other microorganisms provided additional interesting
information. A relatively high number of genes (2566)
mapped to Apicomplexa (most closely related to Plasmo-
dium yoelii) were detected. Fungi (most closely related to 3
yeast including Candida albicans,  Candida glabrata and
Aspergillus spp with some reads showing very distant rela-
tionships to Yarrowia spp and Magnaporthe spp) made up
668 reads. A total of 25 reads were designated as archaea.
Another interesting finding within the metagenomic data
was a high number of sequences (5450) most closely
related to Cyanobacteria. This data could not be verified
Table 2: The 10 sample pool metagenomic analysis comparison to bTEFAP 10 sample pool and bTEFAP 40 sample averages at the 
taxonomic class level.
Class bTEFAP
10 pool %
Metagenomics
10 pool %
bTEFAP 40 avg. %
Bacilli 4.5 4.6 29
Gammaproteobacteria 54 37.4 25
Clostridia 1.1 4.4 12
Betaproteobacteria 2.6 3.6 0.1
Actinobacteria (class) 1.1 19.1 12
Alphaproteobacteria 1.4 7.6 05
deltaproteobacteria 5.4 7.5 0.14
Epsilonproteobacteria 2 13 0.24
Bacteroidetes 10.5 6.1 17.9
other 17.2 8.6 3.5
This table shows the difference in metagenomic and 16s pyrosequencing approach described previously [15]. Also shown is the averages related to 
the 40 individual samples for comparison. The R-squared = 0.74 for correlation between bTEFAP and metagenomics at the class level in the 10 
pooled samples.BMC Microbiology 2009, 9:226 http://www.biomedcentral.com/1471-2180/9/226
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during subsequent analyses and was not noted in any of
the bTEFAP datasets and evidence suggested it may be
human mitochondrial sequence information (data not
shown). However, the most surprising taxonomic rela-
tionship showed that 718 reads were most closely related
to viruses, which was confirmed based upon homology to
the "nr" and "nt" databases of NCBI. These included rela-
tionships to dsDNA viruses, no RNA stage primarily
related to human herpes virus, human adenovirus, Staphy-
lococcus phage, Gryllus bimaculatus virus, Corynebacterium
phage, bacteriophage B3, and a high prevalence of Glypta
fumiferanae ichnovirus related sequences. There were also
a set of reads most closely related to retro-transcribing
virus including tumor viruses, leukemia viruses, and Retic-
uloendotheliosis viruses. Represented within these desig-
nations were gene identifications related to gag-pol
polyproteins, proteases, polymerases, envelope proteins,
viral membrane proteins, capsid-associated proteins, car-
bohydrate binding proteins, fiber proteins, and immedi-
ate early genes. Because most of these reads were only
distantly related to known virus, it is interesting to
hypothesize about the presence of previously undiscov-
ered virus associated with chronic wounds. It has been
shown particularly in burn wounds that herpes virus I can
cause infection and complications and even outbreaks
within burn treatment units [17-19]. The presence of bac-
teriophage-related reads were to be expected considering
the relatively high contribution of bacteria.
Wound topology analysis
We also evaluated a set of 4 VLU using both bTEFAP (Fig-
ure 2) and later a second set of 4 with the newest bTEFAP
Titanium techniques. The goal of this analysis was to
determine how homogeneous (or alternatively how heter-
ogeneous) the bacterial ecology of wounds were across
their surface. Our usual method, when we obtain samples
for molecular diagnostics, indicates we debride larger
areas that include center and edge regions and homoge-
nize to obtain a global picture of the bacterial diversity.
We continue to hold the assumption (backed up by most,
if not all of the recent literature noted previously) that
wounds are by definition very diverse in their microbial
ecology among different samples, but within individual
wounds the diversity is largely uniform. However, the
question remained that (within a single wound) if we
sample small discrete locations, rather than the typical
larger areas we utilize clinically, would we see any varia-
tions in the populations? Figures 2 panels A, B, C, and D
show the general sampling scheme for each of these sam-
ples with the corresponding bTEFAP data provided in
Tables 3, 4, and 5 (data for subject 4 not included). The
images and data associated with these 4 patients, which
were evaluated using the original bTEFAP, provide a good
indication of the topological diversity which may exist
within individual wounds. Subject 1 had uniform occur-
rence of Pseudomonas (tentatively aeruginosa) across the
entire wound with individual sites within the wound con-
taining anaerobes including Porphyromonas, Peptoniphilus,
Finegoldia and Anaerococcus spp. Subject 2 had relatively
high divergence among each of the sampling sites. Coryne-
bacterium was the most uniform bacteria along with Pseu-
domonas  and  Proteus. Several anaerobes were also very
ubiquitous within the individual subsamples including
Anaerococcus, Clostridium and Peptoniphilus. An unknown
Enterobacteriacea was also observed in half of the sub-
samples. Subject 3 was interesting in that anaerobic Pep-
toniphilus  was the most ubiquitous and predominant
bacteria identified followed by Corynebacterium,  Pepto-
streptococcus, Pseudomonas, Staphylococcus, and Streptococ-
cus. This sample indicates the high divergence possible
among such discrete subsamples. Subject 4 was the excep-
tion to the usual high bacterial diversity rule of chronic
wounds and showed nearly 100 percent Pseudomonas in
each of the sub samples. This topological evaluation of
bacterial diversity indicates how important appropriate
sampling is to fully characterize the global wound
ecology.
Utilizing the new bTEFAP titanium technology a second
topology evaluation was also conducted on 4 of the VLU
patients. The new bTEFAP methods utilize the new Tita-
nium chemistry for pyrosequencing, which increases the
read length of individual sequences from an average of
250 bp to over 400 bp, utilize a single PCR step, and
Visual representation of venous leg ulcer sampling strategy Figure 2
Visual representation of venous leg ulcer sampling 
strategy. Panels A-D. These figures provide examples of 
VLU with the transposed sampling locations for the topologi-
cal bacterial diversity evaluation. The letters (e.g. A, B, C,...) 
indicate where each sample was gathered from each of these 
VLU. The detected bacterial diversity for each of these 
wounds is provided in Tables 3, 4, and 5.BMC Microbiology 2009, 9:226 http://www.biomedcentral.com/1471-2180/9/226
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Table 3: Results of topological bacterial diversity analysis for Subject 1 (Figure 2A).
Subject 1 A B C D E F G
Edge Center Center Edge Edge Center Edge
Pseudomonas 89.8 29.9 53.0 7.2 61.7 90.8 23.0
Serratia 2.0 0.0 0.0 0.0 2.1 0.0 4.6
Oxalobacteria 2.0 6.1 0.0 0.0 4.3 0.0 0.0
Porphyromonas 0.0 10.3 11.6 41.7 0.0 0.0 27.5
Peptostreptococcus 0.0 0.0 0.0 6.3 0.0 0.0 1.1
Peptoniphilus 0.0 1.2 3.3 10.4 8.5 0.0 0.0
Finegoldia 0.0 1.2 1.9 8.4 0.0 0.0 1.6
Fastidiosipila sp 0.0 2.5 5.1 2.2 0.0 0.0 2.7
Bordetella sp 0.0 31.0 0.0 0.0 0.0 1.6 0.0
Anaerococcus 0.0 3.7 9.3 5.0 4.3 0.0 10.2
Percentages of each genera are indicated along with their location (A-G) based upon the map indicated in Figure 2A. The location designations 
(edge or center) are also provided.
Table 4: Results of topological bacterial diversity analysis for Subject 2 (Figure 2B).
Subject 2 A B C D E F G H I J K L
L o c a t i o n EEECCCECCCEE
Corynebacterium 87.5 19.0 20.1 0.0 0.0 16.9 27.7 81.4 11.4 53.3 71.9 93.9
Pseudomonas 5.3 15.0 27.0 71.5 2.0 7.2 7.8 0.0 0.0 20.0 6.0 3.2
Proteus 1.8 40.9 30.0 0.0 0.0 10.8 29.7 0.0 8.9 6.7 4.3 0.0
Enterobacteriaceae 1.4 18.1 5.7 0.0 1.6 0.0 12.4 0.0 5.7 0.0 0.0 0.0
Anaerococcus 0.0 0.0 0.0 0.0 0.0 2.4 7.9 0.0 6.5 0.0 0.0 0.0
Clostridia 0.0 0.0 3.1 0.0 0.0 20.5 1.9 1.0 8.9 0.0 2.8 0.0
Haemophilus 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Peptoniphilus 0.0 2.9 6.3 0.0 0.0 38.6 7.1 11.5 50.4 0.0 9.1 0.0
Streptococcus 0.0 0.0 0.0 0.0 84.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Serratia 0.0 0.0 1.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Percentages of each genera are indicated along with their location (A-L) based upon the map indicated in Figure 2B. The location designations (Edge 
or Center; E and C respectively) are also provided.BMC Microbiology 2009, 9:226 http://www.biomedcentral.com/1471-2180/9/226
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incorporate error reading polymerases. This new
approach provides much better resolution at the individ-
ual species level and dramatically enhances our ability to
characterize wound bacterial ecology. Four additional
subjects were evaluated (See additional file 2). The results
were similar to what we observed using the original bTE-
FAP method with the exception that we had more confi-
dence in our ability to resolve certain populations at the
species level. Subject 5 showed a high prevalence of Pseu-
domonas aeruginosa among the majority of the subsam-
ples with notable populations of Burkholdaria spp
(tentatively cenocepacia), an unknown Bacteroidales, and
Clostridium spp (tentatively hathewayi). Subject 6
showed definite ubiquitous detection of Pseudomonas
aeruginosa with notable populations of Streptococcus
parasanguinis across the wound. Subject 7 showed a
remarkable diversity and consistency across the entire
wound with primary populations being Staphylococcus
aureus, Peptoniphilus harei, Staphylococcus capitis, Sta-
phylococcus saprophyticus, Anaerococcus prevotii, and
Finegoldia magna. Finally Subject 8 also showed high
consistency with major populations being Streptococcus
agalactiae, Corynebacterium striatum, Staphylococcus
aureus, with minor contributions in individual sites from
Pseudomonas aeruginosa and Corynebacterium simu-
lans. It should be noted that most of the wounds we have
evaluated in the past have relatively high overall numbers
of bacteria (>105 per mg debridement, based upon quan-
titative molecular methods) so even relatively low per-
centages of individual species such as 2% Anaerococcus
spp. may potentially represents a large number of individ-
ual bacteria propagating within wound biofilms.
Conclusion
Dowd et al [15] first used pyrosequencing to survey
pooled samples of VLU, diabetic foot ulcers and decubi-
tous ulcers and later did a more comprehensive survey of
diabetic foot ulcers [9]. This study takes a similar but more
comprehensive approach with VLU in order to better elu-
cidate the individual ecologies in a large population of
such chronic wounds. Here we show that individual
wounds have distinct ecological footprints. We also show
that within individual wounds there can be both signifi-
cant site specific differences and relative uniformity in the
bacterial ecology. The bottom line appears to be that each
wound must be carefully evaluated and that no single
pathogen is likely to be the causative agent of such infec-
tions. The wound care scientific and clinical opinion lead-
ers have come to accepted the abundance of data showing
that these polymicrobial biofilms represent a primary
impediment to wound healing [9,14,20-22,22-25,25-30].
Based upon the current work and previous efforts we can
deduce that the unique profiles of each individual wound
indicate that a personalized approach to therapeutics
combined with the multiple concurrent strategies of bio-
film-based wound care [26] will revolutionize wound
care. As Tom Pollard indicated in a commentary recently,
biofilm-based wound care is " a significant shift in our
whole approach to wound healing." [31]. Biofilm-based
wound care combined with individualized therapeutic
approaches and accurate rapid molecular diagnostics pro-
vides renewed found hope for those suffering with
chronic wounds.
Methods
General sample collection methods
Patients were identified with VLU that have been persist-
ent for over 6 months. These patients were enrolled in the
study protocol after being educated and signing the
informed consent protocol in compliance with Western
Institutional Review Board approved protocols 56-RW-
004 WIRB® Protocol #20062347. Necessary details of the
study including the protocols, guidelines and require-
ments were thoroughly explained to all the patients. Fol-
lowing these explanations, written consents was obtained
in the presence of a third party witness. A copy of the con-
sent form has been provided to journal editors. The
patients were well informed that they have the right to opt
Table 5: Results of topological bacterial diversity analysis for 
Subject 3 (Figure 2C).
Subject 3 A B C E G D F
EEEEECC
Peptoniphilus 32.1 62.5 49.4 54.2 13.9 44.0 9.6
Corynebacterium 10.7 3.8 2.8 0.0 15.6 0.0 13.1
Stenotrophomonas 14.2 0.0 0.0 0.0 0.0 0.0 0.0
Peptostreptococcus 7 . 16 . 27 . 76 . 16 . 50.0 1.1
Pseudomonas 17.8 7.5 17.1 0.0 21.3 12.0 11.8
Staphylococcus 7.1 2.5 2.3 0.0 31.0 20.0 41.0
Streptococcus 3.6 3.8 1.5 0.0 3.8 4.0 1.7
Acinetobacter 0.0 0.0 2.3 0.0 3.3 0.0 4.4
clostridia 0.0 7.5 3.8 5.5 1.6 8.0 1.5
Porphyromonas 0.0 1.3 0.0 23.7 1.6 0.0 4.3
Prevotella 0.0 0.0 3.6 0.0 0.0 4.0 0.0
Propionibacterium 0.0 0.0 0.0 0.0 0.0 8.0 0.0
Xanthomonas 0.0 0.0 0.0 0.0 0.0 12.0 0.0
Percentages of each genera are indicated along with their location (A-
G) based upon the map indicated in Figure 2C. The location 
designations (edge or center) are also provided.BMC Microbiology 2009, 9:226 http://www.biomedcentral.com/1471-2180/9/226
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out of the study at any time in spite of their written con-
sent. VLU wound beds were debrided to remove superfi-
cial debris and cleansed with sterile saline. With aseptic
precautions, sharp debridement was performed as part of
standard care on the ulcer bed and subsequent samples
collected into sterile 2 ml eppendorf tubes. The samples
were immediately frozen at -80°C.
Wound topology
Eight VLU chosen because they were particularly large and
recalcitrant to healing had a MediRule II template (Briggs
Corporation, Des Moines, IA) placed over the wound and
the wound was outlined on the template grid. Multiple
areas of the wound were chosen on the templates grid sys-
tem and a variety of sample points chosen arbitrarily,
which represented edge and center portions of the wound.
Once these areas were marked on the template and the
wound, the wound was then prepared. This was done by
using normal saline irrigation along with a cotton gauze
to gently remove surface debris. None of the wounds
required local anesthesia and the areas that had been
identified on the wound (as marked on the template)
were then sampled. Individual sterile stainless steel
curettes were used to debride an approximately 1.0 cm
diameter sample of the biofilm down to the host tissue.
Any bleeding at the sample sites was controlled with pres-
sure. The patients reported no additional discomfort from
the procedure. The samples were individually placed in
separate sterile 2 cc Eppendorf tube (Fisher Scientific,
Pittsburgh, PA), labeled with the patient's study accession
number and grid location. The samples were then frozen
at -80°C until subsequent molecular analysis.
DNA extraction
After thawing, the debridement samples were centrifuged
at 14,000 rpm for 30 seconds and resuspended in 500 μl
RLT buffer (Qiagen, Valencia, CA) (with β-mercaptoetha-
nol). A sterile 5 mm steel bead (Qiagen, Valencia, CA) and
500 μl sterile 0.1 mm glass beads (Scientific Industries,
Inc., NY, USA) were added for complete bacterial lyses in
a Qiagen TissueLyser (Qiagen, Valencia, CA), run at 30 Hz
for 5 min. Samples were centrifuged briefly and 100 μl of
100% ethanol added to a 100 μl aliquot of the sample
supernatant. This mixture was added to a DNA spin col-
umn, and DNA recovery protocols were followed as
instructed in the QIAamp DNA Mini Kit (Qiagen, Valen-
cia, CA) starting at step 5 of the Tissue Protocol. DNA was
eluted from the column with 30 μl water and samples
were diluted accordingly to a final concentration of 20 ng/
μl. DNA samples were quantified using a Nanodrop spec-
trophotometer (Nyxor Biotech, Paris, France).
Massively parallel bTEFAP and bTEFAP titanium
Bacterial tag-encoded FLX amplicon pyrosequencing
(bTEFAP) was performed as described previously [9] at
the Research and Testing Laboratory (Lubbock, TX.). The
new bacterial tag-encoded FLX-Titanium amplicon pyro-
sequencing (bTETAP) approach is based upon similar
principles to bTEFAP but utilizes Titanium reagents and
titanium procedures and a one-step PCR, mixture of Hot
Start and HotStar high fidelity taq polymerases, and
amplicons originating from the 27F region numbered in
relation to E. coli rRNA. The bTEFAP procedures were per-
formed at the Research and Testing Laboratory (Lubbock,
TX) based upon RTL protocols http://www.researchand
testing.com.
Bacterial diversity data analysis
Following sequencing, all failed sequence reads, low qual-
ity sequence ends and tags were removed and sequences
were depleted of any non-bacterial ribosome sequences
and chimeras using custom software described previously
[11] and the Black Box Chimera Check software B2C2
(described and freely available at http://www.researchan
dtesting.com/B2C2.html). Sequences less than 150 bp
were removed for the original bTEFAP method and less
than 350 bp for the bTEFAP titanium method. To deter-
mine the identity of bacteria in the remaining VLU
sequences, sequences were first queried using a distrib-
uted BLASTn .NET algorithm [32] against a database of
high quality 16s bacterial sequences derived from NCBI.
Database sequences were characterized as high quality
based upon the criteria of RDP ver 9 [33]. Using a .NET
and C# analysis pipeline the resulting BLASTn outputs
were compiled, validated using taxonomic distance meth-
ods, and data reduction analysis performed as described
previously [9,11,13]. Rarefaction to estimate maximum
diversity in wound using of 220 bp trimmed, non-ribos-
omal sequence depleted, chimera depleted, high quality
reads was performed as described previously [8].
Bacterial identification
Based upon the above BLASTn derived sequence identity
(percent of total length query sequence which aligns with
a given database sequence) and validated using taxo-
nomic distance methods the bacteria were classified at the
appropriate taxonomic levels based upon the following
criteria. Sequences with identity scores, to known or well
characterized 16S sequences, greater than 97% identity
(<3% divergence) were resolved at the species level,
between 95% and 97% at the genus level, between 90%
and 95% at the family and between 80% and 90% at the
order level. After resolving based upon these parameters,
the percentage of each bacterial ID was individually ana-
lyzed for each wound providing relative abundance infor-
mation within and among the VLU based upon relative
numbers of reads within a given sample. Evaluations pre-
sented at a given taxonomic level, except species level, rep-
resent all sequences resolved to their primary genera
identification or their closest relative (where indicated).BMC Microbiology 2009, 9:226 http://www.biomedcentral.com/1471-2180/9/226
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Metagenomics
Metagenomic pyrosequencing reactions were performed
at the Research and Testing Laboratory (Lubbock, TX). In
short, DNA from a pool of 10 VLU preserved at -80°C,
which had been previously analyzed using a 16s rDNA
pyrosequencing microbial diversity approach [15] were
further analyzed. DNA from these same 10 VLU samples
were normalized and combined as described previously.
Rather than perform bacterial 16s analysis as reported pre-
viously a metagenomic (or bulk sequencing) approach
was performed using a half plate bulk sequencing reaction
based upon FLX chemistry (Roche, Indianapolis, IN). In
short, DNA was nebulized to generate 500 bp fragments,
which were then ligated with Roche linkers and subse-
quently utilized to form a high-quality sequencing library,
which was then subjected to massively parallel pyrose-
quencing (Roche, Indianapolis, IN). All methods were
performed using manufacturers' suggested protocols. Fol-
lowing sequencing the individual sequence reads were
screened to provide a final library of quality trimmed
reads > 200 bp. These reads were then analyzed using
IMG/M Expert Review metagenomics analysis system of
the joint genome institute http://www.jgi.doe.gov. Indi-
vidual reads were not assembled prior to analysis and
only reads providing hits based upon IMG/M criteria
[34,35] were utilized in the analyses. Due to HIPAA issues
this data is not publically available but the microbial data
has been deconvoluted and submitted to the SRA as indi-
cated below.
Quantitative PCR
Using a quantitative PCR wound diagnostic panel (Patho-
genius diagnostics, Lubbock, TX), described previously
[12,16] 8 of the 40 VLU samples, chosen because they
contained a predicted predominance of bacteria targeted
by the qPCR wound panel were evaluated. The results of
the qPCR were provided in the form of relative ratios of
each detected bacteria in the sample and these results
compared to corresponding bTEFAP bacterial ratio data.
Data submission and availability at NCBI
The data from the bTEFAP analyses and microbial metage-
nomic data are available in the National Center for Bio-
technology Information' http://www.ncbi.nlm.nih.gov
short read archive (SRA) under project accession number
[GenBank:SRA008389.2/VLU].
Basic Statistics
Statistics were performed using comparative functions
and multivariate hierarchical clustering methods of NCSS
2007 (NCSS, Kaysville, Utah).
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